Nevertheless, CD4+ T cells seem to be of greatest importance, as both SLE patients and lupus-prone mice show a characteristic activation of these cells, and inhibitors normalizing CD4+ T-cell reactions exhibit therapeutic effects. The gene discussed is CD4; the disease is systemic lupus erythematosus.